Acoustically Targeted Chemogenetics for Noninvasive Control of Neural Circuits by Szablowski, Jerzy O. et al.
Articles
https://doi.org/10.1038/s41551-018-0258-2
Acoustically targeted chemogenetics for the  
non-invasive control of neural circuits
Jerzy O. Szablowski   , Audrey Lee-Gosselin, Brian Lue, Dina Malounda and Mikhail G. Shapiro   *
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA. *e-mail: mikhail@caltech.edu
SUPPLEMENTARY INFORMATION
In the format provided by the authors and unedited.
NAture BiOMeDicAL eNGiNeeriNG | www.nature.com/natbiomedeng
Supplementary	information	
Figures:	
	
Supplementary	Figure	1	–	Spatial	targeting	of	ATAC.	
Supplementary	Figure	2	–	Lack	of	AAV9‐mediated	gene	delivery	into	peripheral	neurons.	
Supplementary	Figure	3	–	Gene	expression	following	an	intracranial	injection.	
Supplementary	Figure	4	–	Cued	conditioning	acquisition	during	training.	
Supplementary	Figure	5	‐	Lack	of	AAV9‐mediated	gene	delivery	into	TH‐positive	peripheral	
neurons.	
Supplementary	Figure	6	–	Activity	of	an	activatory	DREADD	in	the	absence	of	CNO.	
Supplementary	Figure	7	–	Tissue	Effects	of	FUS‐BBBO.	
Supplementary	Figure	8	‐	Ultrasound	field	characterization	for	8‐element	annular	array	used	in	the	
study.	
Supplementary	Figure	9	–	Correlation	between	DREADD	expression,	fear	memory	formation	and	
MRI	signal	enhancement.	
	
Tables:	
Supplementary	table	1	–	detailed	statistical	data	on	susceptibility	of	hippocampus	to	transduction	
through	FUS‐BBBO	based	AAV9	delivery.	
	
	
	 	
Supplementary	figures	
	
	
Supplementary	Figure	1	–	Spatial	targeting	of	ATAC.	Additional	brain	sections	from	a	representative	
mouse	 immunostained	 for	hM4Di‐mCherry	 ሺredሻ	6	weeks	 after	FUS‐BBBO	and	 injection	of	AAV9	
encoding	 hM4Di‐mCherry	 under	 the	 CamkIIa	 promoter.	 The	 DAPI	 stain	 demarcates	 cell	 nuclei	
ሺblueሻ.	Scale	bar,	500	µm.	Representative	of	nൌ4	mice	analyzed	by	immunostaining.	
	
	
	
Supplementary	Figure	2	–	Lack	of	AAV9‐mediated	gene	delivery	into	peripheral	neurons.	ሺaሻ	Dorsal	
root	 ganglion	 ሺDRGሻ	 sections	 from	a	 representative	mouse	 immunostained	 for	 a	 positive	 control	
neuronal	 marker	 PGP9.5	 ሺredሻ	 and	 counterstained	 with	 DAPI.	 ሺbሻ	 DRG	 sections	 from	 a	
representative	mouse	 immunostained	for	hM4Di‐mCherry	ሺredሻ	6	weeks	after	a	FUS‐BBBO	and	a	
systemic	injection	of	AAV9	encoding	hM4Di‐mCherry	under	the	CamkIIa	promoter.	The	DAPI	stain	
demarcates	 cell	 nuclei	 ሺblueሻ.	 Scale	 bars,	 50	 µm.	 Expression	 of	 hM4Di‐mCherry	 at	 the	 FUS‐focus	
was	confirmed	in	the	brain	of	all	animals	used	in	this	experiment.	Representative	of	nൌ4	mice.	
	
	
Supplementary	 Figure	3	 –	 Gene	 expression	 following	 an	 intracranial	 injection.	 ሺaሻ	AAV9	 encoding	
inhibitory	DREADD	ሺhM4Di‐mCherryሻ	under	a	CamkIIa	promoter	was	 injected	 intracranially	 into	
both	dorsal	and	ventral	hippocampus.	After	7	weeks	of	expression,	the	percentage	of	positive	cell	
bodies	 showing	 mCherry	 fluorescence	 ሺredሻ	 in	 the	 granular	 cell	 layer	 of	 the	 hippocampus	 was	
counted	at	the	sites	of	injection	and	normalized	to	DAPI	ሺblueሻ.	ሺbሻ	Representative	sections	at	the	
site	of	 injection	showing	mCherry	fluorescence	ሺredሻ	and	DAPI	staining	ሺblueሻ.	Expression	can	be	
seen	in	stratum	oriens	ሺSOሻ	and	some	of	the	cell	bodies	in	pyramidal	layer	ሺSPሻ.	Scale	bar	is	50	µm.	
Representative	of	nൌ4	mice	and	8	injections.	
	
	
Supplementary	 Figure	 4	 –	 Cued	 conditioning	 acquisition	 during	 training.	 ሺaሻ	 Cued	 conditioning	
paradigm.	 Foot	 shocks	 are	 preceded	 by	 30	 s	 audible	 tones,	 and	 freezing	 is	measured	 during	 the	
third	tone	ሺdark	greyሻ.	ሺbሻ	Percentage	of	time	spent	freezing	during	the	third	tone	for	ATAC	mice	
treated	 with	 CNO	 or	 saline	 ሺno	 difference	 detected,	 pൌ0.22,	 two‐tailed,	 Mann‐Whitney	 test	 was	
used	due	to	non‐normal	distributionሻ.	ሺcሻ	Percentage	of	time	spent	 freezing	during	the	third	tone	
for	 wild‐type	 mice	 treated	 with	 CNO	 or	 saline	 ሺno	 difference	 detected,	 pൌ0.17,	 two‐tailed,	
heteroscedastic	 t‐testሻ.	 ሺdሻ	 CNO‐treated	mice	 that	 received	 IV	 injection	 of	 AAV‐DREADD	without	
FUS‐BBBO	ሺno	difference	detected,	pൌ0.44,	two‐tailed,	Mann‐Whitney	test	used	due	to	non‐normal	
distributionሻ.	Bar	graphs	represent	the	mean	േ	SEM.	N	provided	under	each	bar	indicates	number	
of	mice	tested	for	that	experimental	condition.	
	
	
Supplementary	Figure	5	‐	Lack	of	AAV9‐mediated	gene	delivery	into	TH‐positive	peripheral	neurons.	
ሺaሻ	Dorsal	root	ganglion	ሺDRGሻ	sections	from	a	representative	TH‐CRE	mouse	immunostained	for	a	
positive	 control	 tyrosine‐hydroxylase	 neurons	 ሺTH,	 greenሻ	 and	 counterstained	with	DAPI	 ሺblueሻ.	
ሺbሻ	DRG	sections	from	a	representative	mouse	immunostained	for	hM3Dq‐mCherry	ሺredሻ	9	weeks	
after	 a	 FUS‐BBBO	 and	 a	 systemic	 injection	 of	 AAV9	 encoding	 a	 floxed	 DIO‐hM3Dq‐mCherry	
expressed	from	the	Syn1	promoter.	The	DAPI	stain	demarcates	cell	nuclei	ሺblueሻ.	Scale	bars,	50	µm.	
Expression	of	hM3Dq‐mCherry	at	the	FUS‐focus	was	confirmed	in	the	brains	of	all	animals	used	in	
this	experiment.	Representative	of	nൌ4	mice.		
	
		
Supplementary	Figure	6	–	Activity	of	an	activatory	DREADD	in	the	absence	of	CNO.	ሺaሻ	Quantification	
of	 activated	 ሺc‐Fos‐positiveሻ,	 TH‐positive	 neurons	 in	 the	 ATAC‐targeted	 SNc/VTA	 region	 after	
treatment	with	saline,	compared	to	contralateral	control	ሺno	difference	detected,	p	ൌ	0.26,	paired,	
two‐tailed,	 t‐test,	 nൌ4ሻ.	 ሺbሻ	 Representative	 histology	 images	 of	 the	 targeted	 and	 contralateral	
control	brain	regions	stained	for	c‐Fos	ሺyellowሻ,	TH	ሺblueሻ	and	hM3Dq‐mCherry	ሺredሻ.	Scale	bar	is	
100	µm.	Representative	of	nൌ4	mice.	Bar	graphs	represent	the	mean	േ	SEM.	
	
	
Supplementary	Figure	7	–	Tissue	Effects	of	FUS‐BBBO.	ሺaሻ	Classification	of	histological	findings	at	84	
FUS	 sites	 in	 14	mice.	Overall	 71.4%	of	 FUS	 sites	 had	normal	 histology;	 28.6%	of	 sites	 had	 small	
lesions.	ሺbሻ	Images	of	hematoxylin‐stained	tissue	sections	containing	a	typical,	undamaged	FUS	site	
and	 a	 FUS	 site	with	 a	 lesion.	Mice	were	 perfused	 and	 sectioned	 6‐8	weeks	 after	 FUS‐BBBO	 and	
AAV9	injection.	Scale	bars	represent	200	 m	in	the	color	images	and	1	mm	in	the	grayscale	image.	
nൌ14	 mice	 and	 nൌ84	 independently	 targeted	 FUS‐sites	 within	 these	 mice	 were	 analyzed.	 ሺcሻ	
Representative	set	of	sections	at	the	center	of,	and	േ	300	µm	away	from,	a	 lesion‐containing	FUS	
site.	nൌ14	mice	analyzed.	Scale	bars	100	 m.	ሺdሻ	Size	comparison	of	the	average	lesion	found	at	൏	
30%	of	FUS‐BBBO	sites	ሺblueሻ	and	a	33‐gauge	needle	used	for	intracranial	injections	in	mice	ሺgrayሻ.		
Scale	bar,	1	mm.	ሺeሻ	Examples	of	hematoxylin‐stained	tissue	7	weeks	after	the	intracranial	injection	
of	 AAV9‐DREADD.	 A	 loss	 of	 tissue	 at	 and	 around	 the	 needle	 tract	 ሺleft	 and	middle	 panelsሻ	 and	
scarring	could	be	found	at	all	injected	sites.	nൌ3	mice	and	nൌ12	injection	sites	analyzed.	Scale	bars	
are	200	µm.	
	
	
Supplementary	Figure	8	‐	Ultrasound	field	characterization	for	8‐element	annular	array	used	in	the	
study.	 ሺaሻ	 Illustrated	 location	 of	 the	 transducer	 ሺ25	 mm	 diameterሻ	 and	 the	 targeted	 focal	 sites	
ሺorange	dots	labeled	with	focal	distancesሻ	used	in	this	study,	overlaid	on	MRI	image	of	a	mouse	that	
received	FUS‐BBBO	targeted	to	the	SNc/VTA	site	on	the	left	side	of	its	brain	at	a	focal	distance	of	18	
mm.	BBBO	is	indicated	by	bright	T1	contrast	ሺMRI	parameters:	FLASH	2D,	TE	3ms,	TR	100	ms,	slice	
thickness	350	µm,	resolution	80	x	80	µmሻ.	nൌ7	mice	analyzed	by	MRI.	ሺbሻ	Normalized	ultrasound	
pressure	fields	along	the	axis	of	propagation	for	three	focal	distances	as	measured	from	the	face	of	
the	transducer	ሺfൌ18,	16,	14	mmሻ	in	water.	Instrument	characterization	based	on	manufacturer’s	
data,	nൌ1.	 ሺc‐dሻ	Normalized	peak	negative	pressure	 ሺPNPሻ	along	 the	axis	of	propagation	ሺcሻ,	and	
radially	 at	 the	 axial	 peak	 ሺdሻ,	 for	 three	 focal	 distances	 ሺfൌ18,	 16,	 14mmሻ.	 Instrument	
characterization	based	on	manufacturer’s	data,	nൌ1.	Scale	bars	are	1	mm	in	ሺaሻ‐ሺbሻ,	and	the	panels	
are	rendered	at	the	same	scale	to	enable	comparison	between	them.	The	presence	of	skull,	or	other	
aberrating	 or	 reflecting	 tissues	 in	 vivo,	 can	 modify	 the	 appearance	 of	 the	 ultrasound	 beam,	
potentially	resulting	in	a	more	complex	pattern.	
	
	
	
	
Supplementary	Figure	9	–	Correlation	between	DREADD	expression,	fear	memory	formation	and	MRI	
signal	enhancement.	ሺaሻ	Percentage	of	time	spent	freezing	in	the	fear	recall	context	for	ATAC	mice	
treated	with	CNO	or	saline	as	a	 function	of	hM3Dq‐mCherry	expression	 in	dorsal	CA3.	A	negative	
correlation	exists	for	CNO‐treated	mice,	but	not	for	saline‐treated	mice.		Dorsal	CA3	was	chosen	as	a	
site	 of	 interest	 because	 it	 had	 the	 strongest	 and	 most	 consistent	 expression	 throughout	 the	
experimental	 cohort,	 thus	 making	 it	 directly	 comparable.	 Nൌ24	 mice	 analyzed.	 ሺbሻ	 Correlation	
between	 MRI	 signal	 in	 the	 FUS‐targeted	 area	 and	 hM4Di‐mCherry	 expression	 intensity.	 Lack	 of	
correlation	 suggests	 that	 variability	 in	 gene	 expression	 could	 be	 due	 to	 problematic	 tail‐vein	
injections	 of	 the	 virus,	 or	 imperfect	 correspondence	 between	 FUS‐BBBO	 delivery	 of	 viruses	 and	
small	molecules	such	as	Prohance	ሺr2	൏	0.01,	Nൌ8ሻ.		
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Supplementary	Table	 1	 Results	 of	 the	 one‐way	ANOVA	with	 Tukey	HSD	 post‐hoc	 test	 comparing	
susceptibility	 of	 transfection	 of	 different	 fields	 of	 hippocampus	 with	 FUS‐BBBO	 compared	 to	 a	
negative	 control	 ሺuntargeted	 thalamusሻ.	 ሺv	 –	 ventral	 and	 d	 –	 dorsalሻ.	 nൌ5	mice	 tested	 for	 each	
condition.	
	
	
